NSD2 and breast cancer: Tamoxifen-resistant breast cancer cell lines showed increased MMSET expression and concomitant elevated expression of key glycolytic enzymes HK2, G6PD and TIGAR as a consequence of promoter dimethylation at H3K36 by MMSET [234].